Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
206,7 USD | 0,00% | +0,07% | -17,10% |
Attività
- prodotti per cardiologia interventistica, radiologia e urologia (26,5%);
- soluzioni di accesso vascolare (25,9%);
- dispositivi chirurgici (12,5%);
- prodotti per anestesia (11,9%);
- altro (23,2%).
Le vendite nette sono distribuite geograficamente come segue: Stati Uniti (61,8%), Europa (25,5%), Asia-Pacifico (9,1%) e altro (3,6%).
Numero di dipendenti: 14 500
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Americas
57,7
%
| 1 654 | 59,3 % | 1 715 | 57,7 % | +3,73% |
EMEA
19,7
%
| 558 | 20,0 % | 586 | 19,7 % | +4,99% |
Asia
11,7
%
| 306 | 11,0 % | 347 | 11,7 % | +13,25% |
Original Equipment Manufacturer and Development Services
11,0
%
| 273 | 9,8 % | 326 | 11,0 % | +19,58% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
63,2
%
| 1 786 | 64,0 % | 1 880 | 63,2 % | +5,23% |
Europe
22,4
%
| 622 | 22,3 % | 665 | 22,4 % | +6,88% |
Asia Pacific
10,3
%
| 271 | 9,7 % | 308 | 10,3 % | +13,58% |
All Other
4,1
%
| 111 | 4,0 % | 122 | 4,1 % | +9,34% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Liam Kelly
CEO | Chief Executive Officer | 57 | 01/01/09 |
Thomas Powell
DFI | Director of Finance/CFO | 62 | 01/08/11 |
Howard Cyr
CMP | Compliance Officer | - | 01/01/18 |
Michelle Fox
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/13 |
Timothy Duffy
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/12 |
Stephen Klasko
BRD | Director/Board Member | 70 | 01/01/08 |
Lawrence Keusch
IRC | Investor Relations Contact | - | - |
Michael Kryukov
AUD | Comptroller/Controller/Auditor | - | 01/07/07 |
Daniel Logue
LAW | General Counsel | - | 01/01/04 |
Marie Hendrixson
AUD | Comptroller/Controller/Auditor | - | 01/04/09 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Andrew Krakauer
BRD | Director/Board Member | 69 | 01/01/18 |
Stuart Randle
BRD | Director/Board Member | 64 | 01/01/09 |
John Heinmiller
BRD | Director/Board Member | 69 | 01/01/19 |
Candace Duncan
BRD | Director/Board Member | 70 | 01/05/15 |
Director/Board Member | 68 | 13/09/16 | |
Stephen Klasko
BRD | Director/Board Member | 70 | 01/01/08 |
Liam Kelly
CEO | Chief Executive Officer | 57 | 01/01/09 |
Jaewon Ryu
BRD | Director/Board Member | 50 | 05/05/23 |
Neena Patil
BRD | Director/Board Member | 49 | 29/04/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 48 107 248 | 46 979 868 ( 97,66 %) | 1 006 000 ( 2,091 %) | 97,66 % |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Teleflex Medical Pvt Ltd.
Teleflex Medical Pvt Ltd. Medical SpecialtiesHealth Technology Teleflex Medical Pvt Ltd. designs mechanical, electrical and hydraulic controls for the automotive, marine, industrial, medical and aerospace markets. Its products include anaesthesia, cardiac care, interventional access and respiratory. The company is headquartered in Chennai, India. |
Medical Specialties
|
Teleflex Medical Europe Ltd.
Teleflex Medical Europe Ltd. Medical SpecialtiesHealth Technology Part of Teleflex, Inc., Teleflex Medical Europe Ltd. is an Irish company that manufactures and supplies disposable medical products. The private company is located in Ireland. |
Medical Specialties
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-17,10% | 9,74 Mrd | |
-2,31% | 187 Mrd | |
-3,20% | 106 Mrd | |
-5,04% | 66,9 Mrd | |
+0,20% | 49,45 Mrd | |
+17,29% | 48 Mrd | |
+4,06% | 40,84 Mrd | |
+2,07% | 26,48 Mrd | |
+2,36% | 26,25 Mrd | |
+12,96% | 24,62 Mrd |
- Borsa valori
- Azioni
- Azione TFX
- Società Teleflex Incorporated